The first red flag for Marisa Peters was literal: blood on the toilet paper. After the birth of her first child, she noticed symptoms — rectal bleeding, changes to her bowel movements, an urgent need ...

Stage I–II colon cancers are generally managed with surgery alone, often achieving cure rates above 90%, whereas stage III disease commonly requires postoperative chemotherapy for optimal outcomes.

One woman is sharing a look inside her life after completing her cancer treatment. Meagan Meadows was just 24 years old when she found blood in her stool, leading her to medical tests that would ...

Colon cancer is the third most prevalent form of cancer in the U.S., and its incidence is increasing among younger adults, particularly those younger than 50. While colon cancer screening has helped ...

Standard adjuvant chemotherapy for stage III colon cancer consists of a fluoropyrimidine-plus-oxaliplatin regimen. Whether the addition of atezolizumab (an anti–programmed death ligand 1 agent) to a ...

Add Yahoo as a preferred source to see more of our stories on Google. Shambi Broome had virtually no symptoms of colon cancer. She got a colonoscopy when she reached the annual screening age, lowered ...

ROCHESTER, Minn. — Colon cancer is the third most prevalent form of cancer in the U.S., and its incidence is increasing among younger adults, particularly those younger than 50. While colon cancer ...

The ATOMIC Trial shows how adding immunotherapy to chemotherapy may reduce recurrence risk and improve outcomes in stage III dMMR colon cancer. To better understand the role of immunotherapy in colon ...

The Alliance for Clinical Trials in Oncology (Alliance) today announced that the U.S. Food and Drug Administration has accepted for review Genentech's supplemental Biologic License Application for ...

Former model Angie Best has announced her terrifying diagnosis in January this year. She's since shared her treatment journey ...

Meagan Meadows was diagnosed with stage 3 colon cancer at just 24, but she rang the bell after her last round of chemo exactly eight months later Sara Belcher is a digital news writer/editor at PEOPLE ...